<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>There is an increasing body of evidence that a brief exposure to anesthesia induces ischemic tolerance in rat brain (<z:chebi fb="164" ids="38867">anesthetic</z:chebi> preconditioning) </plain></SENT>
<SENT sid="1" pm="."><plain>However, it is unknown whether preconditioning with <z:chebi fb="0" ids="9130">sevoflurane</z:chebi>, a commonly used volatile <z:chebi fb="164" ids="38867">anesthetic</z:chebi> in current clinical practice, produces a delayed window of neuroprotection against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and what the mechanisms are for this protection </plain></SENT>
<SENT sid="2" pm="."><plain>To address these issues, adult male Sprague-Dawley rats were subjected to middle cerebral <z:mp ids='MP_0006134'>arterial occlusion</z:mp> (MCAO) for 2 h </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="9130">Sevoflurane</z:chebi> preconditioning was induced 24 h before <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> by exposing the animals to <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> at 1.0 minimum alveolar concentration (2.4%) in oxygen for 60 min </plain></SENT>
<SENT sid="4" pm="."><plain>Animals preconditioned with <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> had lower neurological deficit scores and smaller brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes than animals with <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> at 6 and 24 h after MCAO, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Application of a selective <z:chebi fb="68" ids="48706">antagonist</z:chebi> for <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> ATP-sensitive <z:chebi fb="120" ids="26216">potassium</z:chebi> (mitoK(ATP)) channel, 5-hydroxydecanoate (5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>, 40 mg/kg i.p.) 30 min before <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> exposure attenuated this beneficial effect </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, protein kinase C ε (PKC ε) was translocated to the membrane fraction at 6 h, but not 24 h, after brain reperfusion in animals preconditioned with <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> and this effect was also abolished by 5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>We concluded that <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> preconditioning induces a delayed neuroprotection and that <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> K(ATP) channels and PKC ε may be involved in this neuroprotection </plain></SENT>
</text></document>